Sanofi's Multaq reduces hospitalization: study (Reuters)

[feedbot]

Sanofi's Multaq reduces hospitalization: study (Reuters)

Reuters - Sanofi-Aventis's experimental drug Multaq significantly reduced the incidence of hospitalization and length of hospital stays in patients with atrial fibrillation, according to a new analysis of a previously reported study, researchers said on Tuesday.

http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_heart_fibrillation_sanofi.html